Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Navier Medical and five other biotechs receive $13.5M in CUREator+ grants to advance AI health and cancer technologies towards market.
Aug 13, 2026•about 2 hours ago
Description
Six biomedical and health tech startups are sharing in $13.5 million from a second investment round from the MRFF-backed CUREator+ program. The startups span inflammatory disease, cancer, cardiovascular disease, neurological disorders, and AI-enabled digital health. CUREator+ offers non-dilutive capital and commercialisation support to accelerate the development of medical innovations. Navier Medical aims to reduce the impact of cardiovascular disease with the help of this funding.
Related People
Suggested for you
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months